Literature DB >> 15002001

Creatinine clearance and signs of end-organ damage in primary hypertension.

G Leoncini1, F Viazzi, D Parodi, E Ratto, S Vettoretti, V Vaccaro, M Ravera, C Tomolillo, G Deferrari, R Pontremoli.   

Abstract

A reduction in renal function is associated with high cardiovascular morbidity and mortality in hypertension. The aim of the present study was to investigate the relationship between creatinine clearance and subclinical organ damage in 957 never previously treated, middle-aged patients with primary hypertension. Renal function was estimated by means of the serum creatinine level using the Cockcroft-Gault formula; left ventricular hypertrophy (LVH) was determined according to electrocardiographic criteria; and retinal vascular changes were evaluated by direct ophthalmoscopy. Creatinine clearance was, on the average, 83+/-21.2 ml/min, and the prevalence of LVH and retinopathy was 13 and 49%, respectively. Creatinine clearance was inversely related to the duration of disease (r=-0.132, P<0.0001), systolic blood pressure (r=-0.110, P=0.001), serum glucose (r=-0.090, P=0.007), total cholesterol (r=-0.196, P<0.0001), and LDL-cholesterol (r=-0.196, P<0.0001). Patients in the lower quintile of creatinine clearance showed a higher prevalence of electrocardiogram (ECG) determined LVH (P=0.04), as well as retinal changes (P=0.02). The risk of having LVH or retinal vascular changes increases significantly with each s.d. decrease in creatinine clearance, regardless of traditional cardiovascular risk factors. Moreover, patients with ECG-determined LVH and retinal changes showed lower creatinine clearance as compared to those with lesser degrees of target organ involvement (P<0.01). In conclusion, a mild reduction in creatinine clearance is associated with preclinical end-organ damage in patients with normal creatinine and primary hypertension. These data may help explain the high cardiovascular mortality observed in patients with renal dysfunction. Routine evaluation of creatinine clearance could be useful for identifying patients at higher cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15002001     DOI: 10.1038/sj.jhh.1001689

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies.

Authors:  Kilian Salerno May; Gary Y Yang; Nikhil I Khushalani; Rameela Chandrasekhar; Gregory E Wilding; Leayn Flaherty; Harish K Malhotra; Richard C Russo; John C Warner; Johnny C Yap; Renuka V Iyer; Chukwumere E Nwogu; Saikrishna S Yendamuri; John F Gibbs; Hector R Nava; Dominick Lamonica; Charles R Thomas
Journal:  J Gastrointest Oncol       Date:  2010-09

2.  Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients.

Authors:  Nelly N Kabedi; Jean-Claude Mwanza; François B Lepira; Tharcisse K Kayembe; David L Kayembe
Journal:  Cardiovasc J Afr       Date:  2014 Sep-Oct       Impact factor: 1.167

3.  Red cell distribution width and inappropriateness of left ventricular mass in patients with untreated essential hypertension.

Authors:  Lizhang Chen; Zhanzhan Li; Yanyan Li; Jing Xue; Peng Chen; Shipeng Yan; Caixiao Jiang; Yingyun Hu; Xing Qiao
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  DBnorm as an R package for the comparison and selection of appropriate statistical methods for batch effect correction in metabolomic studies.

Authors:  Nasim Bararpour; Federica Gilardi; Cristian Carmeli; Jonathan Sidibe; Julijana Ivanisevic; Tiziana Caputo; Marc Augsburger; Silke Grabherr; Béatrice Desvergne; Nicolas Guex; Murielle Bochud; Aurelien Thomas
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

5.  Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results.

Authors:  Lucely Cetina; Lesbia Rivera; José Hinojosa; Adela Poitevin; Jesús Uribe; Carlos López-Graniel; David Cantú; Myrna Candelaria; Jaime de la Garza; Alfonso Dueñas-González
Journal:  BMC Womens Health       Date:  2006-02-07       Impact factor: 2.809

6.  Relationship between Serum Bilirubin and Left Ventricular Hypertrophy in Patients with Essential Hypertension.

Authors:  Tao Zhou; Xiaofang Chen; Zhanzhan Li; Lezhi Li
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

7.  Inter-relationships between left ventricular mass, geometry and arterial stiffness.

Authors:  Manal M Alem; Abdullah M Alshehri
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.